Design Therapeutics Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$12.44

+0.51 (+4.27%)

As of Jun 21, 10:18 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 12 92%

Hold 1 8%

Sell 0 0%

Price Target

Analyst Price Target +373.9% upside

Low Target $40.84

Average Target $58.95

High Target $77.34

Current Price $12.44

Current
$12.44

Target
$58.95

$40.84 $58.95 avg $77.34

Scenario Analysis

Bear Case

$40.84

228.3%

Low target

Base Case

$58.95

+373.9%

Avg target

Bull Case

$77.34

+521.7%

High target

Risk/Reward

2.3x

Favorable

Price in Context

52-Week High

$17.25

-27.9% from high

52-Week Low

$3.33

+273.6% from low

Target vs 52W High

$58.95

+241.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+9.7%
AMGN Amgen Inc	Hold	44	50%	$190.87	-45.0%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+190.0%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-6.4%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.6%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-64.5%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-32.7%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-39.1%